Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Anderton

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Current Opinion in Immunology|October 30, 2004
Post-translational modifications of self antigens: implications for autoimmunityStephen M Anderton
Trends in Immunology|April 4, 2006
Avoiding autoimmune disease--T cells know their limitsStephen M Anderton
Biomedical Journal|June 13, 2015
Peptide immunotherapy in experimental autoimmune encephalomyelitisStephen M Anderton
European Journal of Immunology|November 27, 2010
Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance, easily disturbedStephen M Anderton
Current Opinion in Pharmacology|July 7, 2015
Editorial overview: Immunomodulation: New insights for future treatmentsStephen M Anderton, Simon Fillatreau
European Journal of Immunology|March 30, 2004
Systemic administration of antigen-loaded CD40-deficient dendritic cells mimics soluble antigen administrationKristin Hochweller, Stephen M Anderton
Expert Review of Clinical Immunology|May 19, 2010
B-cell function in CNS inflammatory demyelinating disease: a complexity of roles and a wealth of possibilitiesSimon Fillatreau, Stephen M Anderton
Nature Clinical Practice. Rheumatology|November 28, 2008
Activated B cells in autoimmune diseases: the case for a regulatory roleStephen M Anderton, Simon Fillatreau
European Journal of Immunology|March 10, 2005
Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivoKristin Hochweller, Stephen M Anderton
Immunology|July 21, 2015
Inflammation-associated genes: risks and benefits to Foxp3+ regulatory T-cell functionRichard A O'Connor, Stephen M Anderton
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Current Opinion in Immunology|October 30, 2004
Post-translational modifications of self antigens: implications for autoimmunityStephen M Anderton
Trends in Immunology|April 4, 2006
Avoiding autoimmune disease--T cells know their limitsStephen M Anderton
Biomedical Journal|June 13, 2015
Peptide immunotherapy in experimental autoimmune encephalomyelitisStephen M Anderton
European Journal of Immunology|November 27, 2010
Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance, easily disturbedStephen M Anderton
Current Opinion in Pharmacology|July 7, 2015
Editorial overview: Immunomodulation: New insights for future treatmentsStephen M Anderton, Simon Fillatreau
European Journal of Immunology|March 30, 2004
Systemic administration of antigen-loaded CD40-deficient dendritic cells mimics soluble antigen administrationKristin Hochweller, Stephen M Anderton
Expert Review of Clinical Immunology|May 19, 2010
B-cell function in CNS inflammatory demyelinating disease: a complexity of roles and a wealth of possibilitiesSimon Fillatreau, Stephen M Anderton
Nature Clinical Practice. Rheumatology|November 28, 2008
Activated B cells in autoimmune diseases: the case for a regulatory roleStephen M Anderton, Simon Fillatreau
European Journal of Immunology|March 10, 2005
Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivoKristin Hochweller, Stephen M Anderton
Immunology|July 21, 2015
Inflammation-associated genes: risks and benefits to Foxp3+ regulatory T-cell functionRichard A O'Connor, Stephen M Anderton
Pageof 10